Immatics (NASDAQ:IMTX – Get Free Report) and Quantum Genomics Société Anonyme (OTCMKTS:QNNTF – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, valuation, earnings and dividends. Volatility and Risk Immatics has a […]
Immatics (NASDAQ:IMTX – Get Free Report) shares were down 6.5% during trading on Wednesday . The company traded as low as $11.26 and last traded at $11.30. Approximately 97,936 shares were traded during mid-day trading, a decline of 82% from the average daily volume of 550,190 shares. The stock had previously closed at $12.09. Analyst […]
Immatics (NASDAQ:IMTX – Get Free Report) gapped up prior to trading on Thursday . The stock had previously closed at $11.20, but opened at $11.60. Immatics shares last traded at $11.23, with a volume of 451,625 shares trading hands. Analyst Upgrades and Downgrades Separately, Cantor Fitzgerald began coverage on shares of Immatics in a research […]
Immatics (NASDAQ:IMTX – Get Free Report) and argenx (NASDAQ:ARGX – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, institutional ownership, earnings, risk and valuation. Valuation & Earnings This table compares Immatics and argenx’s top-line […]
Rock Springs Capital Management LP raised its holdings in Immatics (NASDAQ:IMTX – Free Report) by 0.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,536,144 shares of the company’s stock after purchasing an additional 22,221 shares during the quarter. Rock Springs Capital Management […]